
Conference - Natural Products in Drug Discovery and Human Health
I'm just back from the annual Phytochemical Society of Europe conference in Lisbon. A beautiful city, but that is not why we go! This was an interesting mix of standard compound isolation and testing on whatever in house systems are available in the lab, and more complex stories involving full biosynthetic studies, product development and new technologies. An interesting new development is how the Nagoya Protocol and Convention on Biological Diversity have made it near impossible for companies to consider new compounds, at least for now.
